Eisai’s exclusive promotion for ‘Pariet’

Eisai is going to start the exclusive promotion for its representative PPI drug, ‘Pariet(rabeprazole).’

According to the industry concerned on the 22^nd, Janssen and Eisai have recently terminated the joint sales contract for Patiet, a proton pump inhibitor, but its production will still be handled by the Janssen Korea’s factory.

Pariet, a drug that is actually developed by Eisai, has had an i...